Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy.

Ababneh, Hazim S; Frigault, Matthew J; Ng, Andrea K; Patel, Chirayu G

Ababneh, Hazim S; Frigault, Matthew J; Ng, Andrea K; Patel, Chirayu G.

Afiliación

Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Hematol Oncol ; 42(1): e3243, 2024 Jan.

Article en En | MEDLINE | ID: mdl-38103211

Asunto(s)

Linfoma; Receptores Quiméricos de Antígenos; Humanos; Inmunoterapia Adoptiva/efectos adversos; Linfoma/etiología; Tratamiento Basado en Trasplante de Células y Tejidos; Sistema Nervioso Central

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Linfoma Límite: Humans Idioma: En Revista: Hematol Oncol / Hematol. oncol / Hematological oncology Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google